Philip R. Gehrman, PhD

Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania

JCP
Fully Remote Trial of tACS for Treatment of MDD
Original Research

April 22, 2024

Rapid improvement in depression was associated with tACS, particularly for women. Patients can use tACS treatment on their own at home, and it is associated with minimal adverse events.
Philip R. Gehrman, Eric J. Bartky, Curtis Travers, et al
PCC
Brief Report

November 19, 2020

Insomnia and short sleep duration are linked to increased morbidity from cardiometabolic and neuropsychiatric disorders. This study investigated the prevalence and common clinical correlates of insomnia with subjective short...
Ilia Kritikou, Philip R. Gehrman, Diego R. Mazzotti, et al
JCP
Letter to the Editor

April 25, 2018

Elaine M. Boland, Philip R. Gehrman
JCP
Meta-Analysis

September 19, 2017

Acute sleep deprivation is one of the most rapid antidepressant interventions known; however, its benefits are usually short-lived. This meta-analysis synthesizes the existing data on acute sleep deprivation in...
Elaine M. Boland, Hengyi Rao, David F. Dinges, et al
JCP
Article

June 22, 2016

Insomnia and nightmares have been shown to increase the risk for suicidal ideation and suicide. Could simply being awake at night be a risk factor as well? Perlis et...
Michael L. Perlis, Michael A. Grandner, Gregory K. Brown, et al
JCP
Original Research

December 9, 2014

Enda M. Byrne, Uttam K. Raheja, Sarah H. Stephens, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe